SYMFI LO

Peak

efavirenz; lamivudine; tenofovir disoproxil fumarate

NDAORALTABLETPriority Review

Approved

Feb 2018

Lifecycle

Peak

Competitive Pressure

30/100

Company

China - Shanghai

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers